fda glp-1 compounding warning september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Warns Telehealth Firms Over

Oxidative stress, a major contributor to NAFLD development, is exacerbated by inflammation and an overabundance of ROS

Experience the Korean approach to brighter, healthier-looking skin.

That said, ColonBroom is not perfect

Thank you .I purchase from German pharmacies, learnt all about it from this great group

Isolation and identification of bengle (Zingiber cassumunar roxb) as a stimulant in phagocytic activity of macrophages

News outlets started to proclaim the end of body positivity, with headlines like Bye-bye booty: Heroin chic is back and proclaiming 2025 as Shrinking Girl Summer. A new dangerous trend glorifying restrictive eating, #SkinnyTok, went viral